SGShraddha Gulati

Shraddha Gulati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shraddha Gulati has a total of 117 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Endoscopic electroporation in the treatment of a locally advanced colorectal cancer

    by M. A. Noreillie, H. Ayubi, S. Jabak, O. Olabintan, C. Radia, S. Gulati, B. Hayee, S. Thrumurthy, A. Emmanuel, A. Haji

    Text Endoscopic electroporation is a novel technique used in the management of inoperable colorectal and oesophageal cancers. This technique involves the delivery of short electrical pulses to tumour tissues, which transiently increases cell membrane permeability, allowing the passage of calcium ions through the open pores to give a high local cytotoxic effect with minimal adverse systemic effect. In this video we show how this technique is used to treat an inoperable locally advanced obstructing sigmoid adenocarcinoma. Clinical result of this technique has shown excellent safety profile, tumour regression, and marked reduction or cessation of tumour bleeding [1] [2] [3] [4]. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • P282 Artificial intelligence for real-time optical diagnosis of neoplastic polyps during colonoscopy

    by Ishita Barua, Paulina Wieszczy, Shin-Ei Kudo, Masashi Misawa, Øyvind Holme, Shraddha Gulati, Sophie Williams, Kensaku Mori, Hayato Itoh, Kazumi Takishima, et al.

    Background Current colonoscopy practice allows endoscopists to leave tiny hyperplastic polyps in-situ in the rectosigmoid colon if endoscopic diagnosis is done with a high level of accuracy and confidence. Artificial intelligence (AI) is expected to further facilitate this process, however, there are no studies that have evaluated the additional value of using AI in polyp assessment. Methods This is a prospective, open-label, comparative, multicenter trial. We enrolled patients scheduled for screening, surveillance, diagnostic, or therapeutic colonoscopy at three hospitals in Norway, the United Kingdom and Japan. All patients with colorectal polyps ≤ 5 mm in rectosigmoid colon underwent visual inspection to assess polyp histology (adenoma vs non-adenoma). This assessment was done firstly by endoscopists alone followed by an inspection with the aid of the AI device for polyp classification. The primary endpoint was an increased sensitivity to differentiate adenomas with the use of AI. We also evaluated the specificity to differentiate adenomas and confidence level of endoscopists’ prediction as secondary outcome measures. McNemar’s test was used for the analyses. Results Out of the 1,289 recruited participants, we enrolled 531 participants (64% men with average age 67 years, 36% women with average age 65 years) who had colorectal polyps ≤ 5 mm in rectosigmoid colon. A total of 894 eligible polyps (359 adenomas and 535 non-adenomas) of these patients were assessed through visual inspection. There is no significant difference in the sensitivity to differentiate adenomas between endoscopists’ inspection alone and inspection with the aid of AI (88.9% [95% confidence interval, 85.1-91.9] versus 90.5% [87.0-93.4]; Absolute difference 1.7% (95%CI: -1.4-4.7), P=0.33). The specificity to identify adenomas increased with the use of AI (83.6% [80.1-86.6] versus 86.4% [83.2-89.1]; absolute difference 2.8% [95% CI, 0.2-5.4], P=0.03). The confidence level of endoscopists’ prediction also increased from 65.7% to 86.9%. Conclusions Use of AI for polyp classification did not improve the sensitivity to differentiate adenomas in the rectosigmoid colon. However, higher specificity and confidence level in polyp classification under the use of AI may contribute to broader use of optical assessment of polyps and reduction of unnecessary polyp removal and the associated costs.

  • O49 Gaze tracking analysis identifies mechanism for improved adenoma detection with linked colour imaging during colonoscopy

    by Mehul Patel, Shraddha Gulati, Sophie Williams, Andrew Emmanuel, Sri Thrumurthy, Amyn Haji, Bu’hussain Hayee

    Introduction An improvement in adenoma detection rate (ADR) is linked to a reduced risk of interval colorectal cancer and mortality. Linked colour imaging (LCI, Fujifilm) enhances red-white contrast and improved ADR in clinical trials. Identifying the underlying mechanism will help develop future interventions to improve ADR. We used eye tracking technology to establish gaze patterns on white-light (WLE) and LCI and the impact on polyp detection stratified by endoscopist skillset. Methods This prospective study enrolled participants blinded to study hypotheses, stratified by polyp detection rate (PDR): PDR = 0 (non-endoscopist), PDR 1 – 30 and PDR > 30. Participants watched randomised colonoscopy recordings obtained from 2 patients of withdrawal from the caecum to hepatic flexure with WLE, LCI and dye chromoendoscopy whilst eye tracking was performed. We analysed the location and duration of gaze fixations (milliseconds) and time to first fixation for a single polyp present on all image modes (interval when polyp is first visible on a frame to first fixation). We compared gaze metrics between imaging modes stratified by PDR groupings. Results We recruited 33 participants (PRD 0 = 14, PDR 1–30 = 13 and PDR > 30 = 6). There was no significant difference in lifetime procedure count (778.2±720.0 vs 1841.7±1450.0, p = 0.10) and years of practice (7.2±4.7 vs 10.1±6.4, p = 0.35) between PDR 1–30 and PDR>30 groups. All participants had a bias to focus on the vertical midline of the monitor on WLE than the right and left columns based on total duration of fixations (7.22±1.75ms vs 3.47±0.79ms, pConclusions LCI is an effective tool to improve ADR and is associated with faster polyp detection. There may be a learning curve associated with this technology with the greatest benefit for low to average polyp detectors. Eye tracking technology is a powerful tool to evaluate novel image enhancement technologies.

  • ARTIFICIAL INTELLIGENCE FOR REAL-TIME OPTICAL DIAGNOSIS OF NEOPLASTIC POLYPS DURING COLONOSCOPY

    by I. Barua, P. Wieszczy, S.-E. Kudo, M. Misawa, Ø. Holme, S. Gulati, S. Williams, K. Mori, H. Itoh, K. Takishima, et al.

    Aims Artificial intelligence using computer-aided diagnosis (CADx) may enable colonoscopists to distinguish between neoplastic polyps requiring removal and non-neoplastic polyps not requiring removal during colonoscopy. This may reduce costs and resources and prevent polyp overtreatment in colorectal cancer screening. Methods We performed a multicenter clinical trial comparing a novel CADx system using real-time ultra-magnifying polyp visualization during colonoscopy with standard visual inspection of small (≤5mm in diameter) polyps in the sigmoid colon and the rectum for optical diagnosis of neoplastic histology. All polyps were subsequently removed. The primary endpoint was sensitivity for neoplastic polyps compared to histopathology. Secondary endpoints were specificity and colonoscopist confidence level of optical diagnosis. Results We assessed 1,289 individuals for eligibility at colonoscopy centers in Norway, the United Kingdom and Japan. We detected 892 eligible polyps in 518 patients and included them in analyses; 359 neoplastic and 533 non-neoplastic. Sensitivity for diagnosis of neoplastic polyps with standard visual inspection was 88.4% (95% confidence interval (CI) 84.3-91.5) compared to 90.4% (95%CI 86.8-93.1) with CADx (p=0.33). Specificity was 83.1% (95%CI 79.2-86.4) with standard visual inspection and 85.9% (95%CI 82.3-88.8) with CADx (p=0.04). The proportion of polyp assessment with high confidence was 74.2% (95%CI 70.9-77.3) with standard visual inspection versus 92.6% (95%CI 90.6-94.3) with CADx (p<0.001). Conclusions Real-time polyp assessment with CADx did not significantly increase sensitivity for neoplastic polyps, but increased specificity and improved confidence of optical diagnosis. (UMIN no. 000035213; funding Norwegian Research Council, Norwegian Cancer Society, Japan Society for the Promotion of Science) Publication Date: 14 April 2022 (online) © 2022. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer

    by Marco Spadaccini, Michael J Bourke, Roberta Maselli, Marhieu Pioche, Pradeep Bhandari, Jérémie Jacques, Amyn Haji, Dennis Yang, Eduardo Albéniz, Michal Filip Kaminski, et al.

    Objective Endoscopic submucosal dissection (ESD) in a curative intent for submucosa-invasive early (T1) colorectal cancers (T1-CRCs) often leads to subsequent surgical resection in case of histologic parameters indicating higher risk of nodal involvement. In some cases, however, the expected benefit may be offset by the surgical risks, suggesting a more conservative approach. Design Retrospective analysis of consecutive patients with T1-CRC who underwent ESD at 13 centres ending inclusion in 2019 (n=3373). Cases with high risk of nodal involvement (non-curative ESD: G3, submucosal invasion>1000 µm, lymphovascular involvement, budding or incomplete resection/R1) were analysed if follow-up data (endoscopy/imaging) were available, regardless of the postendoscopic management (follow-up vs surgery) selected by the multidisciplinary teams in these institutions. Comorbidities were classified according to Charlson Comorbidity Index (CCI). Outcomes were disease recurrence, death and disease-related death rates in the two groups. Rate of residual disease (RD) at both the previous resection site and regional lymph nodes was assessed in the surgical cases as well as from follow-up in the follow-up group. Results Of 604 patients treated by colorectal ESD for submucosally invasive cancer, 207 non-curative resections (34.3%) were included (138 male; mean age 67.6±10.9 years); in 65.2% of cases, no complete resection was achieved (R1). Of the 207 cases, 60.9% (n=126; median CCI: 3; IQR: 2–4) underwent surgical treatment with RD in 19.8% (25/126), while 39.1% (n=81, median CCI: 5; IQR: 4–6) were followed up by endoscopy in all cases. Patients in the follow-up group had a higher overall mortality (HR=3.95) due to non-CRC causes (n=9, mean survival after ESD 23.7±13.7 months). During this follow-up time, tumour recurrence and disease-specific survival rates were not different between the groups (median follow-up 30 months; range: 6–105). Conclusion Following ESD for a lesion at high risk of RD, follow-up only may be a reasonable choice in patients at high risk for surgery. Also, endoscopic resection quality should be improved. Trial registration number NCT03987828.


  • Open Access

    Artificial intelligence in luminal endoscopy

    by Shraddha Gulati, Andrew Emmanuel, Mehul Patel, Sophie Williams, Amyn Haji, Bu’hUssain Hayee, Helmut Neumann

    Artificial intelligence is a strong focus of interest for global health development. Diagnostic endoscopy is an attractive substrate for artificial intelligence with a real potential to improve patient care through standardisation of endoscopic diagnosis and to serve as an adjunct to enhanced imaging diagnosis. The possibility to amass large data to refine algorithms makes adoption of artificial intelligence into global practice a potential reality. Initial studies in luminal endoscopy involve machine learning and are retrospective. Improvement in diagnostic performance is appreciable through the adoption of deep learning. Research foci in the upper gastrointestinal tract include the diagnosis of neoplasia, including Barrett’s, squamous cell and gastric where prospective and real-time artificial intelligence studies have been completed demonstrating a benefit of artificial intelligence–augmented endoscopy. Deep learning applied to small bowel capsule endoscopy also appears to enhance pathology detection and reduce capsule reading time. Prospective evaluation including the first randomised trial has been performed in the colon, demonstrating improved polyp and adenoma detection rates; however, these appear to be relevant to small polyps. There are potential additional roles of artificial intelligence relevant to improving the quality of endoscopic examinations, training and triaging of referrals. Further large-scale, multicentre and cross-platform validation studies are required for the robust incorporation of artificial intelligence–augmented diagnostic luminal endoscopy into our routine clinical practice.


  • Open Access

    402 OUTCOMES FROM AN INTERNATIONAL MULTICENTRE REGISTRY OF PATIENTS WITH ACUTE GASTROINTESTINAL BLEEDING UNDERGOING ENDOSCOPIC TREATMENT WITH HEMOSPRAY

    by Durayd Alzoubaidi, Radu Rusu, Jason M. Dunn, Johannes W. Rey, Shraddha Gulati, Bu Hayee, Selena Dixon, Sulleman Moreea, Duncan Napier, John Anderson, et al.


  • Elective endoscopic clipping for the treatment of symptomatic diverticular disease: a potential for ‘cure’

    by Amyn Haji, Aris Plastiras, Monica Ortenzi, Shraddha Gulati, Andrew Emmanuel, Bu’hUssain Hayee

    We present the prospective series of elective endoscopic clipping with the aim of treating all visible diverticula in patients with previous bleeding, resulting in near-complete disappearance of DD.